Related Experiment Video
Updated: Aug 12, 2026
07:54
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
Published on: October 25, 2011
Statistical considerations for immunohistochemistry panel development after gene expression profiling of human
Rebecca A Betensky1, Catherine L Nutt, Tracy T Batchelor
1Department of Biostatistics, Harvard School of Public Health, 655 Huntington Ave., Boston, Massachusetts 02115, USA. betensky@hsph.harvard.edu
The Journal of Molecular Diagnostics : JMD
|April 29, 2005
Summary
This study introduces a simulation method to determine the necessary sample size for immunohistochemistry studies, crucial for classifying human tumors and improving cancer patient prognoses using gene expression data.
Area of Science:
- Genomics
- Pathology
- Biostatistics
Background:
- Microarray expression studies classify tumors using differentially expressed genes.
- Immunohistochemistry (IHC) extends gene expression data to paraffin-embedded tissues.
- The required number of IHC assays for classification is often unclear.
Purpose of the Study:
- To propose a simulation-based method for sample size assessment in IHC investigations.
- To estimate the number of IHC assays needed for developing and validating marker panels.
- To improve prognostic classification of cancer patients.
Main Methods:
- Utilized preliminary gene expression data from human tumor studies.
- Developed a simulation approach to estimate sample size for IHC assays.
- Applied the method to design an IHC study for glioma classification.
Main Results:
- Estimated the number of IHC assays required for technical and prognostic validation.
- Demonstrated that simulation-based assumptions are more realistic than crude analytic calculations.
- Showcased the utility of preliminary gene expression data for sample size estimation.
Conclusions:
- Simulation approaches based on existing gene expression data are powerful for designing follow-up genomic studies.
- The proposed method enables efficient and powered sample size calculations for IHC studies.
- This approach aids in the development of robust marker panels for improved cancer prognosis.
